BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2020-00179 Clinical feasibility of minimally supervised therapy after stroke with a hand rehabilitation robot (ReHapticKnob): pilot and main study clinical trial medical devices monocentric C2 Dr. med. Paolo Rossi Rehabilitation Engineering Laboratory, ETH Zurich Clinica Hildebrand Centro di riabilitazione Brissago, Brissago
Comitato etico cantonale Ticino 24.02.2020 Study has ended
2020-00178 Surgical site infection in paediatric cardiac surgery – retrospective analysis of available data personal data/biological material monocentric Prof. Alexander Kadner Inselspital Bern Inselspital Bern, Bern
Kantonale Ethikkommission Bern 05.03.2020
2020-00176 Studies on hematopoietic cell samples from the BioBank of the Flow Cytometry Laboratory of HUG personal data/biological material monocentric Prof Thomas Matthes HUG HUG, Geneva
Commission Cantonale d'éthique de la recherche Genève (CCER) 28.04.2020
2020-00175 Predictors of early re-intervention after ureteral tumorstent insertion for obstructive uropathy personal data/biological material monocentric Dr. med. Etienne Xavier Keller UniversitätsSpital Zürich UniversitätsSpital Zürich, Zürich
Kantonale Ethikkommission Zürich 10.03.2020
2020-00174 Use of normal hemaopoietic stem cells and mesenchymal stem cells in 3-dimensional in vitro cultures personal data/biological material monocentric Prof Thomas Matthes HUG HUG, Geneva
Commission Cantonale d'éthique de la recherche Genève (CCER) 09.03.2020
2020-00173 A Precision Medicine Approach for Innovative Outbreak Investigation using Machine Learning Methods personal data/biological material monocentric Andrew Atkinson Inselspital Inselspital, Bern
Kantonale Ethikkommission Bern 10.03.2020
2020-00172 A Randomized, Multi-center, Phase 3 Study of Nivolumab in Combination with Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line Treatment in Participants with Advanced Hepatocellular Carcinoma More ... clinical trial drugs phase 3 multicentric C Dr. med. Bristol-Myers Squibb International Corporation Iuliana-Pompilia Radu, Berne
Universitätsspital Zürich, Zürich
Kantonale Ethikkommission Bern Kantonale Ethikkommission Zürich 08.07.2021 Study has ended
2020-00171 Therapeutic consequences of screening for de novo donor-specific HLA-antibodies after kidney transplantation non clinical, involving persons monocentric A Prof. Stefan Schaub Universitätsspital Basel, Abteilung für Transplantationsimmunologie und Nephrologie, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 10.03.2020
2020-00170 La désinfection du tissu sous-cutané diminue-t-elle la contamination du champ opératoire par P. acnes par rapport à une dissection au bistouri électrique lors d’une chirurgie primaire de l’épaule ? clinical trial other clinical trials monocentric A PD Dr Beat Kaspar Moor Hôpital du Valais Service orthopédie, Hôpital du Valais, 1920 Martigny
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 02.02.2021 Study has ended
2020-00169 Exenatide-test for diagnosing endogenous hyperinsulinemic hypoglycemia clinical trial drugs phase 2 monocentric B Dr. Kwadwo Antwi University Hospital Basel University Hospital Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 12.06.2020 Study has ended
2020-00168 SEcondary Prevention and Outcome after ACUTE ISCHEMIC STROKE (AIS) – SEPAIS – in three Different Socio- Economic Environments non clinical, involving persons monocentric A PD Dr. med. Mirjam Heldner Neurology of University Hospital of Bern University hospital of Bern, Departement of Neurology, Bern
Kantonale Ethikkommission Bern 05.11.2020
2020-00167 Kidney biopsy findings in patients diagnosed with myelodysplastic syndome personal data/biological material monocentric Prof Fadi Fakhouri CHUV - Néphrologie CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 05.05.2020
2020-00166 GO41717: A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF TIRAGOLUMAB, AN ANTI-TIGIT ANTIBODY, IN COMBINATION WITH ATEZOLIZUMAB COMPARED WITH PLACEBO IN COMBINATION WITH ATEZOLIZUM More ... clinical trial drugs phase 3 multicentric C Prof. Dr. med. Dr. rer. nat. Markus Jörger Roche Pharma (Schweiz) AG Kantonsspital St. Gallen, St. Gallen
Inselspital Bern, Bern
Kantonsspital St. Gallen, St. Gallen
Centre Hospitalier Universitaire Vaudois, Lausanne
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Bern, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 23.04.2020 Study has ended
2020-00165 CAIN457M2301E1, A Multicenter, Double-blind, Randomized Withdrawal extension study of subcutaneous secukinumab to demonstrate long-term efficacy, safety and tolerability insubjects with moderate to se More ... clinical trial drugs phase 3 multicentric B PD Dr med Emmanuel Laffitte Novartis Pharma Schweiz AG Hopitaux Universitaire Geneve, 1205 Geneva
Inselspital Bern, Freiburgstrasse 34, 3010 Bern
CHUV Centre hospitalier universitaire vaudois, Avenue de Beaumont 29, 1011 Lausanne
Commission Cantonale d'éthique de la recherche Genève (CCER) Kantonale Ethikkommission Bern, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 08.06.2020 Study has ended
2020-00163 Characterization of neutralizing monoclonal antibodies against the novel coronavirus (2019-nCoV) and of cross-reactive monoclonal antibodies with neutralizing activity against various beta-coronavirus More ... non clinical, involving persons monocentric A Davide Corti Humabs BioMed (VIR Bellinzona) Humabs Biomed/ VIR Bellinzona, Bellinzona
Comitato etico cantonale Ticino 07.02.2020
2020-00162 EBV-specific cell mediated immunity and EBV-associated disease in solid-organ transplant recipients personal data/biological material monocentric PD Dr Oriol Manuel CHUV - BH 10 549 Centre Hospitalier Universitaire Vaudois, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 29.06.2020
2020-00160 Tolerance induction of patients with carboplatin or taxane hypersensitivity in gynaecological oncology allows to achieve optimal treatment according to international standards. personal data/biological material monocentric Dr. med. Céline Montavon Sartorius Universitätsspital Frauenklinik Basel University hospital, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 05.02.2020
2020-00159 Triceps-sparing extra-articular step-cut olecranon osteotomy for distal humeral fractures non clinical, involving persons monocentric A PD Dr Beat Kaspar Moor Hôpital du Valais Hôpital du Valais, 1920 Martigny
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 05.02.2021
2020-00157 Evaluation of the InterlACE coding strategy for bilateral cochlear implant users clinical trial medical devices monocentric C1 Prof.Dr. Norbert Dillier Universitätsspital Zürich ORL-Klinik USZ, Zürich
Kantonale Ethikkommission Zürich 06.10.2020 Study has ended
2020-00156 Evolution de la consommation d’alcool après bypass gastrique non clinical, involving persons monocentric A Dr Francisco Da Rocha Hopital Universitaire de Genève Hopitaux Universitaire de Genève, Genève
Commission Cantonale d'éthique de la recherche Genève (CCER) 14.07.2020